Home > Boards > US Listed > Medical - Drugs > Abbvie (ABBV)

ABBV 2Q19 results:

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 728
Posts 109,895
Boards Moderated 15
Alias Born 09/05/02
160x600 placeholder
New Long-Term Data Continues to Demonstrate Progression-Free Survival and Overall Survival Benefits with VENCLEXTA®/ VENCLYX... PR Newswire (US) - 12/8/2019 7:30:00 AM
More than Seven-Year Analysis of Early Treatment with IMBRUVICA® (ibrutinib) Monotherapy Showed Improved Progression-Free Su... PR Newswire (US) - 12/7/2019 9:00:00 AM
Extended Follow-up Phase 3 Data Underscore Sustained Efficacy and Safety of IMBRUVICA® (ibrutinib) in the Treatment of Chron... PR Newswire (US) - 12/7/2019 7:33:00 AM
IMBRUVICA® (ibrutinib) Plus VENCLEXTA®/VENCLYXTO® (venetoclax) Combination Data Show High Rates of Disease Clearance in Pr... PR Newswire (US) - 12/7/2019 7:30:00 AM
Alector Announces Phase 1 Data on AL002 at the 12th Clinical Trials on Alzheimer’s Disease (CTAD) Meeting GlobeNewswire Inc. - 12/6/2019 4:30:10 PM
Form 8.3 - [Allergan plc] Dow Jones News - 12/6/2019 9:49:00 AM
AbbVie conclut une entente avec l'Alliance pancanadienne pharmaceutique (APP) relativement à SKYRIZI[MC] (risankizumab) pour... PR Newswire (Canada) - 12/6/2019 6:08:00 AM
AbbVie reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for SKYRIZI™ (risankizumab) for the Treatm... PR Newswire (Canada) - 12/6/2019 6:08:00 AM
Form 8.3 - [Allergan plc] Dow Jones News - 12/5/2019 9:39:00 AM
Form 8.3 - Allergan Plc Dow Jones News - 12/4/2019 9:54:00 AM
Form 8.3 - Allergan Plc Dow Jones News - 12/3/2019 10:43:00 AM
Form 8.3 - [Allergan Plc] Dow Jones News - 12/2/2019 9:59:00 AM
Form 8.3 - [Allergan Plc] Dow Jones News - 11/27/2019 10:04:00 AM
Form 8.3 - Allergan Plc Dow Jones News - 11/26/2019 10:07:00 AM
Form 8.3 - [Allergan plc] Dow Jones News - 11/25/2019 9:13:00 AM
Form 8.3 - [Allergan Plc] Dow Jones News - 11/22/2019 10:03:00 AM
Harpoon Therapeutics Shares Rise on Expanded Deal With AbbVie Dow Jones News - 11/21/2019 12:35:00 PM
Form 8.3 - [Allergan plc] Dow Jones News - 11/21/2019 9:45:00 AM
Harpoon, AbbVie Ink New, Expanded Agreements Dow Jones News - 11/21/2019 8:58:00 AM
AbbVie to Present Latest Clinical Research in the Treatment of Leukemias, Lymphomas and Other Blood Cancers at 2019 ASH Annua... PR Newswire (US) - 11/21/2019 8:30:00 AM
Dragonfly Therapeutics annonce une collaboration avec AbbVie visant les maladies auto-immunes et l'oncologie PR Newswire (Canada) - 11/21/2019 7:35:00 AM
Harpoon Therapeutics and AbbVie Announce Licensing and Option Collaboration to Advance HPN217, Harpoon’s BCMA-Targeting Tri... GlobeNewswire Inc. - 11/21/2019 4:00:00 AM
Form 8.3 - [Allergan plc] Dow Jones News - 11/20/2019 9:47:00 AM
Dragonfly Therapeutics to Collaborate With AbbVie Dow Jones News - 11/20/2019 9:44:00 AM
Dragonfly Therapeutics Announces Collaboration with AbbVie for Autoimmune Diseases and Oncology PR Newswire (US) - 11/20/2019 8:00:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist